PIXIUM VISION
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | ALPIX |
| ISIN: | FR001400JX97 |
PIXIUM VISION news, videos and press releases
For more news please use our advanced search feature.
PIXIUM VISION - More news...
PIXIUM VISION - More news...
- 10/09/2023 - 17:00 Pixium Vision announces the opening of safeguard proceedings
- 07/28/2023 - 17:00 Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing shares
- 07/11/2023 - 05:00 Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing facility
- 05/24/2023 - 17:00 Annual Meeting of Shareholders June 13, 2023 / Availability of preparatory documents
- 04/21/2023 - 05:00 Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023
- 04/03/2023 - 05:00 Communication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMD
- 02/16/2023 - 17:38 Second convening of the Extraordinary Shareholder Meeting on March 8, 2023
- 12/28/2022 - 06:00 Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products
- 12/15/2022 - 06:00 Pixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024
- 10/21/2022 - 05:00 Pixium Vision announces its cash position at 30 September 2022 and provides an update on its activities
- 10/04/2022 - 05:00 Pixium Vision announces participation in investor conferences and events in October 2022
- 09/06/2022 - 05:00 Pixium Vision announces participation in upcoming investor conferences in September 2022
- 08/29/2022 - 05:00 Pixium Vision announces participation in upcoming scientific conferences in September 2022
- 08/11/2022 - 16:00 Pixium Vision to attend H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17, 2022
- 07/26/2022 - 05:00 Pixium Vision announces successful implantation of first patient in the Netherlands in Prima System European pivotal trial PRIMAvera
- 07/22/2022 - 05:00 Pixium Vision announces its financial results for H1 2022 and provides a business update
- 04/29/2022 - 17:00 Pixium Vision announces the availability of its audited financial statements for the financial year 2021
- 04/28/2022 - 05:00 Results of Combined General Meeting held on April 19, 2022
- 04/19/2022 - 05:00 Pixium Vision announces its cash position at 31 March 2022 and provides an update on its activities and financial outlook until the end of 2022
- 04/04/2022 - 05:00 Combined General Meeting of April 19, 2022: Availability of preparatory documents
- 03/29/2022 - 05:00 Pixium Vision announces FDA approval of clinical trial expansion of Prima System US feasibility study to Stanford Medicine
- 03/24/2022 - 06:00 Pixium Vision to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest on March 28 - 30
- 03/14/2022 - 18:00 Pixium Vision convenes a Combined General Meeting of Shareholders on April 19, 2022
- 02/22/2022 - 06:00 Pixium Vision announces its unaudited financial results for 2021 and provides a business update
- 01/27/2022 - 06:00 Pixium Vision announces the publication in Nature Communications of peer-reviewed clinical data demonstrating the clinical benefit of the Prima System in Dry AMD patients
- 12/14/2021 - 06:00 Pixium Vision to attend 11th Annual LifeSci Partners Corporate Access Event
- 12/08/2021 - 06:00 Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK
- 10/22/2021 - 06:56 Pixium Vision announces its cash position at 30 September 2021 and provides an update on its activities and financial outlook until the end of 2022
- 09/23/2021 - 05:00 Pixium Vision announces implantation of first patient in Germany in Prima System European pivotal trial PRIMAvera
- 09/08/2021 - 05:00 Pixium Vision expands collaboration with Stanford University on next generation Prima System implants
